top of page
MarmosetAstrocytes_GFAP_Image2 low brightness.jpg

Welcome to the Galvan Lab

Mapping the molecular pathways that link aging to Alzheimer's disease

We seek to understand the molecular processes of aging that drive Alzheimer's disease (AD), and to define the therapeutic potential of drug candidate molecules in treating AD.
We use genetic manipulations in rodents, in vivo optical and MRI- and PET-based brain imaging, laser Doppler-based cerebral blood flow measures, primary cell culture systems and a range of biochemical, cellular and molecular biology approaches, together with single-cell -omic and behavioral tools.
Our ultimate goal is to advance our understanding of age-related neurodegenerations, including AD, and to identify potential interventions to treat them or delay their progression.

 

Home: Project
AAV-BI30-YFP transduction brain high mag.tif

Brain vascular endothelial cell senescence
in Alzheimer's disease

Regulation of metabolism by neuronal mTORC1

RxA tam-cre female smaller.jpg

mTOR-driven brain microvascular aging in Alzheimer's disease

Vascular tau in Alzheimer's and other tauopathies

Tau-induced astrocyte senescence in Alzheimer's disease

Astrocytes%20made%20senescent%20by%20tau%20copy_edited.jpg
bottom of page